Approved / Repurposing Libraries
Approved Drug Libraries (Drug Repurposing Libraries) are the most effective tool for "drug repurposing" – identifying new indications for existing drugs. These collections (e.g., from TargetMol) contain high-purity compounds already approved by regulatory bodies (e.g., FDA, EMA) or in advanced stages of clinical testing for oncology, cardiology, immunology, and more. Do you have a new biological target and need a compound with a known safety profile? Start your screening with our approved drug library to dramatically accelerate the journey from bench to bedside.
Product sorting
3 items total
List of products
Listing controls
3 items total
Approved drug libraries represent the fastest path to clinical application. They consist exclusively of compounds that have passed clinical trials or are currently FDA/EMA-approved.
Advantages of Drug Repurposing
- Safety: Established toxicological profiles and human safety data (Phase I).
- Speed: Potential for "Fast Track" progression directly to Phase II trials for new indications.
- Pharmacokinetics: Well-documented ADME (absorption, distribution, metabolism, and excretion) parameters.
They are the most valuable component of our general bioactive libraries.
